At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 54 enrolled
Drug / intervention
Prochlorperazine +4 moredrug
Likely dose
Prochlorperazine 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Check Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine. A Multi-Center, Randomized Double-Blind, Clinical Control Trial.
University Medical Center of Southern Nevada·interventional·Posted Jan 15, 2016·Updated Dec 11, 2017
In Brief
A Phase 4 clinical trial evaluating Prochlorperazine, Ketamine, and 3 other interventions for Headache. Completed, enrolled 54 participants across 1 site.
Detailed Summary
This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeadache
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 2016
Enrollment StartMar 2016
Primary CompletionMar 2017
TodayJul 2026
First PostedJan 15, 2016
Enrollment StartMar 17, 2016
Primary CompletionMar 21, 2017
TodayJul 2, 2026
Enrollment to primary: 1.0 yearsPosted 10.5 years ago
Interventions
Prochlorperazinedrug
prochlorperazine 10 mg IV
Ketaminedrug
Ketamine 0.3 mg/kg IV
Diphenhydraminedrug
Diphenhydromine 25 mg IV
Ondansetrondrug
Ondansetron 4 mg IV
Normal Salinedrug
Normal Saline 500 cc IV Bolus